Tirzepatide
GIP / GLP-1 receptor co-agonist. C20 fatty diacid moiety.
from $54.5010 mg · 15 mg · 20 mg · 30 mg · 60 mg
GIP / GLP-1 / glucagon receptor tri-agonist. Investigational.
Research use only. Not for human or veterinary use. Not approved by Health Canada and carries no DIN. Molecular weight and CAS are literature values for the base compound; the lot COA is the authoritative description of the material supplied.
GIP / GLP-1 receptor co-agonist. C20 fatty diacid moiety.
GLP-1 receptor agonist. Aib8 substitution, C18 diacid side chain.
Acylated long-acting amylin analogue. Amylin and calcitonin receptor activity.
Tyr-hGH (177–191). C-terminal growth hormone fragment.